Narval
PrivateLast Round
Accelerator
May 29, 2024
Total Funding Raised
$4.02M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Narval is a biotechnology company that develops synthetic Antibody Mimetic Proteins™ designed to replace conventional monoclonal antibodies in therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Defense Tech
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Narval Comparables
Compare Narval with similar companies based on industry and business-model similarity.
Narval Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 29, 2024 | ||||
| Accelerator | Mar 11, 2024 | ||||
| Seed | Jul 10, 2023 |
Key People
Founding team and executive leadership
Narval Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| MedTech Innovator | Accelerator |
| Techstars | Accelerator |
| Fabric Ventures | Seed |
| Prelude | Seed |
| Motier Ventures | Seed |
| BioTools Innovator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 35% MoM, reaching 3.8K.
- Mar 11, 2024
$20K round led by Techstars
Narval Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Narval's valuation, stock price, and market status.